Chorioamnionitis and subsequent bronchopulmonary dysplasia in very-low-birth weight infants: a 25-year cohort

A R Ballard1, L H Mallett1, J E Pruszynski2

  • 1Department of Pediatrics, Texas A&M Health Science Center, Temple, TX, USA.

Insights

Sepsis, a serious bloodstream infection, is linked to bronchopulmonary dysplasia (BPD) in premature infants. Chorioamnionitis (CA), an infection of the membranes surrounding the fetus, did not show an association with BPD in this study.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Infectious Diseases

Background:

  • Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants.
  • Chorioamnionitis (CA) and sepsis are potential risk factors for BPD.
  • Understanding these associations is crucial for improving infant outcomes.

Purpose of the Study:

  • To investigate the association between chorioamnionitis (CA) or sepsis and the development of BPD.
  • To analyze a large cohort of very-low-birth weight (VLBW) infants over 25 years.

Main Methods:

  • Retrospective review of 1,687 VLBW infants (gestational age ≤32 weeks) admitted between 1989 and 2014.
  • BPD defined by the National Institutes of Health consensus definition; CA defined clinically.
  • Logistic regression models used to identify predictors of BPD, controlling for gestational age.

Main Results:

  • 44% of infants developed moderate or severe BPD.
  • Lower gestational age, sepsis, and later birth year (≥1995) were significant predictors of BPD.
  • Chorioamnionitis (CA) was not significantly associated with BPD.

Conclusions:

  • Sepsis is independently associated with an increased risk of developing moderate or severe BPD in VLBW infants.
  • Chorioamnionitis (CA) does not appear to be associated with BPD in this cohort.
  • Findings highlight the importance of managing sepsis in premature infants to prevent BPD.
Abstract

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...